Clinical Trials for Recurrent Skin Squamous Cell Carcinoma

Find clinical trials for recurrent skin squamous cell carcinoma. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

NCT ID: NCT06568172

This clinical trial is studying whether adding an immunotherapy drug called cemiplimab to standard treatment (surgery with or without radiation) can improve outcomes for patients with advanced skin...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, Cleveland, Ohio, United States +89 more

A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer

NCT ID: NCT04315701

This clinical trial is studying a medication called cemiplimab, which is an immunotherapy treatment that helps the body’s immune system fight high-risk skin cancer. The trial focuses on patients wi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Los Angeles, California, United States, Chicago, Illinois, United States +3 more

Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer

NCT ID: NCT04428671

This clinical trial is studying a treatment called cemiplimab for patients with high-risk cutaneous squamous cell carcinoma (cSCC), which is a type of skin cancer. The trial aims to see how well ce...

Recruiting

Phase: PHASE1 Type: interventional Locations: Atlanta, Georgia, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions